The immuno-oncology pathway in humans includes cytokines involved in cancer and the immune system’s interaction with tumors. Key cytokines in this pathway include IL-2, IFNγ, IL-10, and Rantes. These cytokines are critical for understanding tumor immunology, immune evasion by tumors, and the effectiveness of immunotherapies. They are essential for research into cancer treatments and for monitoring the immune environment in oncology studies. Signosis’ Human Immuno-Oncology ELISA Strip Assay quantitatively profiles and measures 8 cytokines associated with the immuno-oncology pathway. The list of cytokines is as follows: TNFα, IFNγ, IL-1β, IL-2, IL-6, IL-10, IL-12, and Rantes.